Skip to Content

Dextrose (50%) Injection

Last Updated: December 19, 2017
Status: Current

Dextrose (50%) Injection

Products Affected - Description
  • 50% Dextrose intravenous injection, Amphastar
    50 mL Luer-Jet syringe, 10 count (NDC 76329-3301-01)

 
50% Dextrose intravenous injection, Pfizer
50 mL LifeShield syringe, 10 count (NDC 00409-4902-34)
50 mL Ansyr II Luer Lock syringe, 10 count (NDC 00409-7517-16)
50 mL vial, 25 count (NDC 00409-6648-02)
Reason for the Shortage
    • Amphastar has 50% dextrose injection on shortage due to increased demand.
    • Pfizer has 50% dextrose injection on shortage due to manufacturing delays.
Available Products
  • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Amphastar has 50% dextrose 50 mL syringes on allocation and is regularly releasing product.
    • Pfizer has 50% dextrose 50 mL LifeShield syringes available in limited supply. The 50% dextrose 50 mL vials and 50 mL Ansyr II syringes are on back order and the company estimates a release date of mid-January 2018.

Safety

  • FDA has extended the expiration dating for certain lots of 50% dextrose 50 mL Abboject syringes.

Updated

December 19, November 15, October 2, September 1, August 11, July 30, 14 and 6, June 16 and 6, May 2, April 20, 2017, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide